An Open-label, Multi-center Trial to Examine the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease Previously Enrolled in C87059 (COSPAR I, NCT00349752).
18 Years
N/A
Both
Crohn's Disease
Trial Information
An Open-label, Multi-center Trial to Examine the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease Previously Enrolled in C87059 (COSPAR I, NCT00349752).
Inclusion Criteria:
- Patients previously enrolled in C87059 (COSPAR I, NCT00349752)
Exclusion Criteria:
- Subject withdrawn or discontinued from C87059 (COSPAR I, NCT00349752) study under
specific conditions
- Subject who received treatment other than study medication and other than medications
permitted in C87059 (COSPAR I, NCT00349752)
- Subjects from countries where certolizumab pegol is authorized in Crohn's disease
treatment
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Occurrence of at Least One Treatment-emergent Adverse Event During This Study (Maximum 122 Weeks)
Outcome Description:
Results are presented as the number of subjects with at least one treatment-emergent adverse event during this study.
Outcome Time Frame:
During this study (maximum 122 weeks)
Safety Issue:
No
Principal Investigator
UCB Clinical Trial Call Center
Investigator Role:
Study Director
Investigator Affiliation:
+1 877 822 9493 (UCB)
Authority:
United States: Food and Drug Administration
Study ID:
C87065
NCT ID:
NCT00356408
Start Date:
January 2007
Completion Date:
February 2010
Related Keywords:
- Crohn's Disease
- CDP870
- certolizumab pegol
- Crohn's Disease
- Crohn Disease
Name | Location |
|---|---|
| Hinsdale, Illinois 60521 | |
| Bettendorf, Iowa 52722 | |
| Alexandria, Minnesota 56308 | |
| Albany, Georgia 31701 | |
| Birmingham, Alabama 35294 | |
| Fountain Valley, California 92708 | |
| Miami, Florida 33176 | |
| Columbia, Missouri 65203 | |
| Albany, New York 12208 | |
| Cleveland, Ohio 44195 | |
| Nashville, Tennessee 37203-1632 | |
| Austin, Texas 78705 | |
| Seattle, Washington 98195 | |
| Flint, Michigan 48532 | |
| Louisville, Kentucky 40207 | |
| McLean, Virginia 22101 | |
| Kansas City, Kansas 66160 | |
| Metairie, Louisiana 70006 | |
| Denver, Colorado | |
| Baltimore, Maryland 21287 | |
| Boston, Massachusetts | |
| Charlotte, North Carolina | |
| South Burlington, Vermont | |
| Milwaukee, Wisconsin | |
| Indianapolis, Indiana | |
| Charleston, South Carolina | |
| Tulsa, Oklahoma | |
| Salt Lake City, Utah 84112 |
